Ethyl chloroformate → HCID 86663155, Verbindung

HRID 1626573Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1626573
Cl.[Cl:2][C:3]1[N:4]=[C:5]([N:12]2[CH2:17][CH2:16][O:15][CH2:14][C@@H:13]2[CH3:18])[C:6]2[CH2:11][NH:10][CH2:9][C:7]=2[N:8]=1.Cl[C:20]([O:22][CH2:23][CH3:24])=[O:21].C([O-])(O)=O.[Na+]>C1COCC1>[Cl:2][C:3]1[N:4]=[C:5]([N:12]2[CH2:17][CH2:16][O:15][CH2:14][C@@H:13]2[CH3:18])[C:6]2[CH2:11][N:10]([C:20]([O:22][CH2:23][CH3:24])=[O:21])[CH2:9][C:7]=2[N:8]=1

Komponenten

5

Versuchsvorschrift

(S)-4-(2-chloro-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl)-3-methylmorpholine hydrochloride (intermediate 6) (330 mg, 1.3 mmol), was dissolved in dry THF with srirring and treated with ethyl chloroformate (136 uL, 1.4 mmol) and NaHCO3 (218 mg, 2.6 mmol) at room temperature (20° C.) overnight. The mixture was concentrated in vacuo and the residue purified by flash chromatography using a mixture of 0-100% petrol ether/ethyl acetate as eluent, yielding the title compound (475 mg, 1.46 mmol, 41%).

Aufarbeitung

  1. concentrationThe mixture was concentrated in vacuo
  2. customthe residue purified by flash chromatography
  3. additiona mixture of 0-100% petrol ether/ethyl acetate as eluent

Quellen und Nachweise

ORD-Eintrag
ord-1a1589f3524742e4b53365bdfa546d2c
Quelldatensatz
uspto-grants-2014_07
Patentnummer
US08785457B2

Notizen zur Reaktion

Wird geladen…